Fig. 4

Cost-effectiveness acceptability curve for Pola-R-CHP vs. R-CHOP. Abbreviations: Pola-R-CHP, polatuzumab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone; R-CHOP, rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.